These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17962426

  • 21. A randomized pahse I bioequivalence clinincal trial of a paediatric fixed-dose combination antiretroviral reconstitutable suspension in healthy adult volunteers.
    Esseku F, Joshi A, Oyegbile Y, Edowhorhu G, Gbadero D, Adeyeye M.
    Antivir Ther; 2013; 18(2):205-12. PubMed ID: 23653910
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.
    Manosuthi W, Kiertiburanakul S, Chaovavanich A, Sungkanuparph S.
    J Med Assoc Thai; 2007 Feb; 90(2):244-50. PubMed ID: 17375627
    [Abstract] [Full Text] [Related]

  • 24. Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.
    Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E.
    AIDS; 2007 Mar 30; 21(6):768-71. PubMed ID: 17413701
    [Abstract] [Full Text] [Related]

  • 25. Negligence. Liver transplant patient too late to sue Viramune maker.
    AIDS Policy Law; 2003 Mar 28; 18(6):7. PubMed ID: 12712930
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection.
    Sabo JP, Lamson MJ, Leitz G, Yong CL, MacGregor TR.
    AAPS PharmSci; 2000 Mar 28; 2(1):E1. PubMed ID: 11741217
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical safety of a generic fixed-dose combination of stavudine/lamivudine/névirapine (Triomune). Study of 297 cases in Togo].
    Mouhari-Touré A, Saka B, Kombat K, Tchangaï-Walla K, Pitche P.
    Bull Soc Pathol Exot; 2008 Dec 28; 101(5):404-6. PubMed ID: 19192611
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours.
    Moodley D, Pillay K, Naidoo K, Moodley J, Johnson MA, Moore KH, Mudd PN, Pakes GE.
    J Clin Pharmacol; 2001 Jul 28; 41(7):732-41. PubMed ID: 11452705
    [Abstract] [Full Text] [Related]

  • 34. Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
    L'homme RF, Kabamba D, Ewings FM, Mulenga V, Kankasa C, Thomason MJ, Walker AS, Chintu C, Burger DM, Gibb DM.
    AIDS; 2008 Mar 12; 22(5):557-65. PubMed ID: 18316996
    [Abstract] [Full Text] [Related]

  • 35. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD, Kang W, Lee HW, Park DJ, Ahn JH, Kim MJ, Kim EY, Kim SW, Nam HS, Na HJ, Yoon YR.
    Clin Ther; 2009 Apr 12; 31(4):793-803. PubMed ID: 19446152
    [Abstract] [Full Text] [Related]

  • 36. Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.
    Currier J, Lazzarin A, Sloan L, Clumeck N, Slims J, McCarty D, Steel H, Kleim JP, Bonny T, Millard J, ASCENT study team.
    Antivir Ther; 2008 Apr 12; 13(2):297-306. PubMed ID: 18505181
    [Abstract] [Full Text] [Related]

  • 37. Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children.
    Bergshoeff AS, Fraaij PL, Verweij C, van Rossum AM, Verweel G, Hartwig NG, de Groot R, Burger DM.
    J Antimicrob Chemother; 2004 Dec 12; 54(6):1152-4. PubMed ID: 15537694
    [Abstract] [Full Text] [Related]

  • 38. Fixed dose combination of lamivudine, stavudine and nevirapine in the treatment of pediatric HIV infection: a preliminary report.
    Pensi T.
    Indian Pediatr; 2007 Jul 12; 44(7):519-21. PubMed ID: 17684304
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
    Aweeka FT, Kang M, Yu JY, Lizak P, Alston B, Chung RT, AIDS Clinical Trials Group 5092s Study Team.
    HIV Med; 2007 Jul 12; 8(5):288-94. PubMed ID: 17561874
    [Abstract] [Full Text] [Related]

  • 40. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
    Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, Masaba R, Odhiambo P, Fowler MG, Weidle PJ, Thigpen MC.
    Antimicrob Agents Chemother; 2009 Mar 12; 53(3):1170-6. PubMed ID: 19114673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.